Temasek, the Singapore government-owned sovereign fund, has started discussions with private equity (PE) entities to offload its stake in Bangalore-based Medreich Pharma.
A contract drug manufacturer, Medreich claims a client base spread across 54 countries. Major clients include GlaxoSmithKline, Pfizer, Sanofi Aventis, Wyeth, Adcock Ingram, Mylan and Actavis. Its website says Medreich manufactures two of the top-selling drugs for GSK and Pfizer in India. Full story
